Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
56 /100
HIGH RISK
Score updated Oct 13, 2026

CTXR — Citius Pharmaceuticals, Inc. Dilution Risk Tracker

Track CTXR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CTXR — Get alerts when the score changes →

As of October 13, 2026, Citius Pharmaceuticals, Inc. (CTXR) has a DilutionWatch DilutionScore of 56/100, rated HIGH dilution risk. Citius Pharmaceuticals, Inc. has a market capitalization of $13.71M, 27.45M shares outstanding, 15 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $250.00M, 17.62M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
50
💰 Cash Runway
65
📊 Float Risk
35
⚠️ Warrant Exposure
90
🔄 Convertible Debt
15

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 57%
🔄 Reverse Split model est. 65%
• 50-day avg $0.74 below $1 exchange minimum
• 7 months cash with weak price
📜 Warrant Exercise model 60%
• Massive warrant overhang: 64% of shares outstanding
• Warrant risk score very high (90/100)
💰 Capital Raise model 33%
• Under 12 months cash (7mo)
• Active ATM program with $250M remaining capacity
🔔 Track CTXR — Get forecast alerts →

Market Data

Market Cap$13.71M
Shares Outstanding27.45M
Float26.96M
Cash$17.01M
Debt$808.2K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore56/100DilutionWatch score record
Shares Outstanding27.45MVerified float table or market cache
Public Float26.96MVerified float table or market cache
Market Cap$13.71MMarket data cache
Cash Runway7.1 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$250.00MSEC-derived dilution fields
Outstanding Warrants17.62MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 4.

Recent SEC source mix: 424B5 1, 8-K 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 113.4% shares (2026Q1 vs prior)
15 institutional holders · 14.78M shares
#1 ARMISTICE CAPITAL, LLC 9.19M shares
#2 BANK OF AMERICA CORP /DE/ 3.84M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 1.07M shares
+ 12 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest5.59M
Days to Cover30.5
% of Float20.7%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-14
xbrl XBRL CONVERTIBLE 2016-12-23
424B5 ATM 2026-04-24
8-K 8K EVENT 2026-04-24
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual CTXR Dilution Snapshot

Citius Pharmaceuticals, Inc. (CTXR) has a DilutionScore of 56/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

CTXR's DilutionScore is currently 56/100 (High risk), with 3 score changes tracked over 89 days. The score improved from 49/100 (Medium risk).

Period Score Risk Level Duration
Oct 01 – Oct 13, 202656/100HIGH13 days
Sep 17 – Sep 30, 202649/100MEDIUM14 days
Aug 22 – Sep 16, 202648/100MEDIUM26 days
Jul 16 – Aug 21, 202665/100HIGH36 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

CTXR shares outstanding have decreased 0.0% from 27.45M (May 2026) to 27.45M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 25, 202627.45M26.96M▲ 0.02%
May 18, 202627.45M26.95M▲ 22.69%
May 03, 202627.45M21.97M▲ 0.39%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track CTXR Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment CTXR files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking CTXR — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for CTXR
CTXR FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.